Annual Cash & Cash Equivalents
$11.96 M
-$29.14 M-70.90%
December 31, 2023
Summary
- As of February 8, 2025, FBRX annual cash & cash equivalents is $11.96 million, with the most recent change of -$29.14 million (-70.90%) on December 31, 2023.
- During the last 3 years, FBRX annual cash & cash equivalents has fallen by -$46.80 million (-79.65%).
- FBRX annual cash & cash equivalents is now -79.65% below its all-time high of $58.77 million, reached on December 31, 2020.
Performance
FBRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.36 M
-$8.13 M-33.21%
September 30, 2024
Summary
- As of February 8, 2025, FBRX quarterly cash and cash equivalents is $16.36 million, with the most recent change of -$8.13 million (-33.21%) on September 30, 2024.
- Over the past year, FBRX quarterly cash and cash equivalents has increased by +$4.40 million (+36.80%).
- FBRX quarterly cash and cash equivalents is now -72.16% below its all-time high of $58.77 million, reached on December 31, 2020.
Performance
FBRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
FBRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.9% | +36.8% |
| 3 y3 years | -79.7% | +36.8% |
| 5 y5 years | - | +36.8% |
FBRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.5% | at low | -62.9% | +36.8% |
| 5 y | 5-year | -79.7% | at low | -72.2% | +36.8% |
| alltime | all time | -79.7% | at low | -72.2% | +36.8% |
Forte Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.36 M(-33.2%) |
| Jun 2024 | - | $24.50 M(-19.5%) |
| Mar 2024 | - | $30.44 M(+154.5%) |
| Dec 2023 | $11.96 M(-70.9%) | $11.96 M(-43.4%) |
| Sep 2023 | - | $21.14 M(+3.5%) |
| Jun 2023 | - | $20.44 M(-43.1%) |
| Mar 2023 | - | $35.90 M(-12.6%) |
| Dec 2022 | $41.10 M | $41.10 M(-6.7%) |
| Sep 2022 | - | $44.05 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $38.55 M(-3.7%) |
| Mar 2022 | - | $40.03 M(-4.8%) |
| Dec 2021 | $42.04 M(-28.5%) | $42.04 M(-7.9%) |
| Sep 2021 | - | $45.66 M(-10.1%) |
| Jun 2021 | - | $50.80 M(-7.2%) |
| Mar 2021 | - | $54.76 M(-6.8%) |
| Dec 2020 | $58.77 M | $58.77 M(+191.3%) |
| Sep 2020 | - | $20.18 M(-27.3%) |
| Jun 2020 | - | $27.75 M |
FAQ
- What is Forte Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Forte Biosciences?
- What is Forte Biosciences annual cash & cash equivalents year-on-year change?
- What is Forte Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Forte Biosciences?
- What is Forte Biosciences quarterly cash and cash equivalents year-on-year change?
What is Forte Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of FBRX is $11.96 M
What is the all time high annual cash & cash equivalents for Forte Biosciences?
Forte Biosciences all-time high annual cash & cash equivalents is $58.77 M
What is Forte Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, FBRX annual cash & cash equivalents has changed by -$29.14 M (-70.90%)
What is Forte Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of FBRX is $16.36 M
What is the all time high quarterly cash and cash equivalents for Forte Biosciences?
Forte Biosciences all-time high quarterly cash and cash equivalents is $58.77 M
What is Forte Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, FBRX quarterly cash and cash equivalents has changed by +$4.40 M (+36.80%)